Stock RDG READ-GENE S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Company Read-Gene S.A.

Equities

RDG

PLRADGN00014

Biotechnology & Medical Research

End-of-day quote Warsaw S.E.
Other stock markets
 18:00:00 2024-05-30 EDT 		5-day change 1st Jan Change
4.74 PLN +0.42% Intraday chart for Read-Gene S.A. -0.84% -18.28%
05-14 Read-Gene S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
02-12 Read-Gene S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI

Business Summary

Read-Gene SA is a Poland-based company active in the biotechnology sector. It is focused on technologies which aim is to detect, prevent and treat malignant tumors. The Company specializes in three fields: chemoprevention, clinical trials and genetic testing. It offers breast cancer, colon cancer and prostate cancer tests, as well as, medical consultancy, DNA tests and supplements. The Company operates one wholly owned subsidiary, Dieta Antyrakowa Read-Gene Sp. z o.o. Its major shareholder is GEN-PAT-MED Sp. z o.o.

Number of employees: 27

Sales per Business

PLN in Million2022Weight2023Weight Delta
Medical Research and Testing
99.6 %
7 99.6 % 10 99.6 % +40.11%
Goods and Materials
0.4 %
0 0.4 % 0 0.4 % +47.84%

Sales per region

PLN in Million2022Weight2023Weight Delta
Poland
100.0 %
7 100.0 % 10 100.0 % +40.13%

Managers

Managers TitleAgeSince
Jan Lubinski CEO
 Chief Executive Officer - -
Karolina Ertmanska DFI
 Director of Finance/CFO - -
Karolina Kleszcz ADM
 Chief Administrative Officer - -
Róza Derkacz IRC
 Investor Relations Contact - -
Slawomir Szymoniak AUD
 Comptroller/Controller/Auditor - -

Members of the board

Members of the board TitleAgeSince
Adam Gliszczynski BRD
 Director/Board Member - -
Tomasz Huzarski CHM
 Chairman - -
Jacek Gronwald BRD
 Director/Board Member - -
Janusz Piróg BRD
 Director/Board Member - -
Adam Szuba BRD
 Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 9,449,731 2,340,279 ( 24.77 %) 0 24.77 %

Company contact information

Read-Gene SA

ul. Alabastrowa 8 Grzepnica

72-003, Dobra

+48 91 433 4256

http://www.read-gene.com
address Read-Gene S.A.(RDG)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Diagnostics & Testing

Sales per Business

Sector Bio Diagnostics & Testing

1st Jan change Capi.
READ-GENE S.A. Stock Read-Gene S.A.
-18.28% 14.18M
EXACT SCIENCES CORPORATION Stock Exact Sciences Corporation
-38.56% 8.39B
GUARDANT HEALTH, INC. Stock Guardant Health, Inc.
+0.18% 3.32B
IOVANCE BIOTHERAPEUTICS, INC. Stock Iovance Biotherapeutics, Inc.
+9.29% 2.48B
BGI GENOMICS CO., LTD. Stock BGI Genomics Co., Ltd.
-18.21% 2.06B
VERACYTE, INC. Stock Veracyte, Inc.
-24.57% 1.59B
MARAVAI LIFESCIENCES HOLDINGS, INC. Stock Maravai LifeSciences Holdings, Inc.
+32.37% 1.15B
SEEGENE, INC. Stock Seegene, Inc.
-7.64% 704M
CAREDX, INC Stock CareDx, Inc
+8.42% 678M
ADAPTIVE BIOTECHNOLOGIES CORPORATION Stock Adaptive Biotechnologies Corporation
-29.59% 508M
Bio Diagnostics & Testing
  1. Stock Market
  2. Equities
  3. RDG Stock
  4. Company Read-Gene S.A.